Using the Acapella device to improve lung function in bronchiectasis patients
Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis.
This study is testing if using the Acapella device for 15 minutes a day can help improve lung function in people with bronchiectasis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 40 Years to 55 Years |
| Sex | All |
| Sponsor | South Valley University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT05838144 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Acapella device in improving spirometry measures in patients diagnosed with bronchiectasis. Participants will be divided into two groups: one group will use the Acapella device three times a day for 15 minutes over a week, in addition to their usual medications and chest physical therapy, while the control group will only receive medications and routine physical therapy. Spirometry tests, including forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1), will be conducted before and after the intervention period to assess any changes in lung function.
Who should consider this trial
Good fit: Ideal candidates are bronchiectasis patients aged 40 to 55 who are cooperative.
Not a fit: Patients with severe cardiac disorders, uncontrolled hypertension, or uncontrolled diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance lung function and overall respiratory health in patients with bronchiectasis.
How similar studies have performed: There is limited information on similar studies, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. bronchiectasis patients. 2. Age range between 40 to 55 years old of both gender. 3. Cooperative patients. Exclusion Criteria: 1. Patients with severe cardiac disorders. 2. Un controlled hypertensive patients. 3. Un controlled diabetic patients.
Where this trial is running
Cairo
- Shymaa yussuf abo zaid — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: Shymaa Y Abo zaid — Lecturer
- Study coordinator: Shymaa Y Abo zaid
- Email: shaymaayoussef397@gmail.com
- Phone: 01010941685
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.